Convatec Group Plc

Convatec Group Plc, a mid-cap in the Pharmaceuticals & Biotechnology sector, saw its stock decline significantly during trading. Despite a year-to-date increase, its performance lags behind the FTSE 100. The company has shown modest growth in operating profit and maintains a notable debt-to-equity ratio and return on equity.

Convatec Group Plc saw a significant rise on November 13, 2025, outperforming the FTSE 100. The company, with a market cap of GBP 4,788 million, reported a solid operating cash flow but faces challenges with high debt levels. Its recent performance reflects resilience in a competitive market.

Convatec Group Plc's stock faced a significant decline today, reaching an intraday low amid a challenging trading session. Over the past week and month, the company's stock has shown notable decreases, contrasting with the modest gains of the FTSE 100. Long-term growth indicators present a mixed outlook for the company.